“A 2026 study reported cyclooctasulfur in mouse and human cells and described its antioxidant role through sulfur-derived compounds.”

Checks out so far. 2 hold up so far.

0.9140 under ledger-default@0.3.0 at snapshot 27745 for all claims together. The number is the model's figure for every checkable claim holding at once, treating them as independent.

The statement as a whole, read from the 2 claims below. Each claim is scored on its own; this reading only counts them. Provisional until audited.

Review 25% done · 0% counted in review coverage · 25% by the claims' own author only (2 claims, 8 checks)

Share:

Checked in Galedra: score 0.91, strongly supported · not yet reviewed by anyone else “A 2026 study reported cyclooctasulfur in mouse and human cells and described its antioxidant role through sulfur-derived compounds.” https://galedra.org/investigations/01a0eb0e-8fe4-78b6-b7f6-f62b1fff51b5

“A 2026 study detected cyclooctasulfur (S₈) in both mouse and human cells, with high levels in mitochondria and lipid droplets.”

Supported · 0.9970 under ledger-default@0.3.0 at snapshot 27745 · review checks 0 of 4 · provisional until audited.

0 of 4 review checks done · 0 counted

See the evidence · Claim card

“The study reported that mammalian cells can use S₈ to produce hydropersulfides that act as antioxidants.”

Supported · 0.9168 under ledger-default@0.3.0 at snapshot 27745 · review checks 0 of 4 · provisional until audited.

2 of 4 review checks done · 0 counted · 2 by the author only

See the evidence · Claim card